MRI-LINAC based radiation treatments are currently being used for selected patient populations and body regions, and knowledge related to the outcomes of this modality is progressing. The outcome and long-term side effects in comparison with other modern LINAC are now being studied. As contouring, planning, quality assessment and treatment assessment require new techniques for the use of all team members, including technicians, dosimetrists and physicians, research reporting on these factors and each stage of the process is needed for medical professionals. Furthermore, as physicians report a low incidence of acute side effects, with almost none for long-term follow-up, this knowledge should be published amongst the radiation milieu.
The goal of this issue is to collect and summarise the growing knowledge from institutions using MRI-LINAC, in order to share the obstacles, solutions, learning curves and innovations of this new treatment modality.
We welcome Original Research, Reviews, Perspectives, and Methods, related to (but not limited to) the adoption and use of MRI-LINAC for physicians, clinicians and other associate personnel, short term studies for specific malignant disease (prostate, pancreas, lung, etc.), patient reported outcome measures, safety measures, and multidisciplinary perspectives related to MRI guided radiation therapy.
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
MRI-LINAC based radiation treatments are currently being used for selected patient populations and body regions, and knowledge related to the outcomes of this modality is progressing. The outcome and long-term side effects in comparison with other modern LINAC are now being studied. As contouring, planning, quality assessment and treatment assessment require new techniques for the use of all team members, including technicians, dosimetrists and physicians, research reporting on these factors and each stage of the process is needed for medical professionals. Furthermore, as physicians report a low incidence of acute side effects, with almost none for long-term follow-up, this knowledge should be published amongst the radiation milieu.
The goal of this issue is to collect and summarise the growing knowledge from institutions using MRI-LINAC, in order to share the obstacles, solutions, learning curves and innovations of this new treatment modality.
We welcome Original Research, Reviews, Perspectives, and Methods, related to (but not limited to) the adoption and use of MRI-LINAC for physicians, clinicians and other associate personnel, short term studies for specific malignant disease (prostate, pancreas, lung, etc.), patient reported outcome measures, safety measures, and multidisciplinary perspectives related to MRI guided radiation therapy.
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
